☰

Naomi Hodgins, Ph.D. - Publications

Affiliations: 
2012-2016 Institute of Pharmaceutical Science King's College London, London, UK 
 2017-2018 Leo Pharma 
 2019- Technical Services Pfizer, Inc., San Diego, CA, United States 
Area:
Liposomes, Pharmaceutical Science
Tree Info Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Wang JT, Hodgins NO, Al-Jamal WT, Maher J, Sosabowski JK, Al-Jamal KT. Organ Biodistribution of Radiolabelled γδ T Cells Following Liposomal Alendronate Administration in Different Mouse Tumour Models. Nanotheranostics. 4: 71-82. PMID 32190534 DOI: 10.7150/ntno.32876  0.721
2017 Dubey RD, Klippstein R, Wang JT, Hodgins N, Mei KC, Sosabowski J, Hider RC, Abbate V, Gupta PN, Al-Jamal KT. Novel Hyaluronic Acid Conjugates for Dual Nuclear Imaging and Therapy in CD44-Expressing Tumors in Mice In Vivo. Nanotheranostics. 1: 59-79. PMID 29071179 DOI: 10.7150/ntno.17896  0.701
2017 Hodgins NO, Wang JT, Al-Jamal KT. Nano-technology based carriers for nitrogen-containing bisphosphonates delivery as sensitisers of γδ T cells for anticancer immunotherapy. Advanced Drug Delivery Reviews. 114: 143-160. PMID 28694026 DOI: 10.1016/J.Addr.2017.07.003  0.702
2017 Hodgins NO, Al-Jamal WT, Wang JT, Klippstein R, Sosabowski JK, Marshall JF, Maher J, Al-Jamal KT. Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28432037 DOI: 10.1016/J.Jconrel.2017.04.025  0.734
2017 Ingallina C, Costa PM, Ghirga F, Klippstein R, Wang JT, Berardozzi S, Hodgins N, Infante P, Pollard SM, Botta B, Al-Jamal KT. Polymeric glabrescione B nanocapsules for passive targeting of Hedgehog-dependent tumor therapy in vitro. Nanomedicine (London, England). PMID 28322108 DOI: 10.2217/Nnm-2016-0388  0.715
2016 Mohamed Suffian IF, Wang JT, Hodgins NO, Klippstein R, Garcia-Maya M, Brown P, Nishimura Y, Heidari H, Bals S, Sosabowski JK, Ogino C, Kondo A, Al-Jamal KT. Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo. Biomaterials. 120: 126-138. PMID 28056402 DOI: 10.1016/J.Biomaterials.2016.12.012  0.534
2016 Hodgins NO, Al-Jamal WT, Wang JT, Parente-Pereira AC, Liu M, Maher J, Al-Jamal KT. In vitro potency, in vitro and in vivo efficacy of liposomal alendronate in combination with γδ T cell immunotherapy in mice. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27664328 DOI: 10.1016/J.Jconrel.2016.09.023  0.738
2015 Rubio N, Mei KC, Klippstein R, Costa PM, Hodgins N, Wang JT, Festy F, Abbate V, Hider RC, Chan KL, Al-Jamal KT. Solvent-Free Click-Mechanochemistry for the Preparation of Cancer Cell Targeting Graphene Oxide. Acs Applied Materials & Interfaces. 7: 18920-3. PMID 26278410 DOI: 10.1021/Acsami.5B06250  0.654
Show low-probability matches.